The global manufacturing execution system market size is estimated to be worth USD 3.99 billion in 2024 and is anticipated to reach USD 20.46 billion by 2035 at a CAGR of 16.02% during the forecast period.

Manufacturing Execution System providers in healthcare market is the rising realm amongst stakeholders in pursuit to connect, monitor and control the complex manufacturing process. Every year, the healthcare industry generates a massive amount of data. In fact, the healthcare data currently constitutes around 30% share of the global data volume. Further, it is estimated that, by 2025, the data generated via the healthcare sector will rise at a compound annual growth rate of 36%.

According to industry experts, MES has the potential to reduce 10%-30% of the overall production cost depending on the type of industry.  It has further been observed that companies are increasingly adopting cloud-based manufacturing execution system, to overcome the challenges associated with growing complexity of processes and global expansion of businesses.  Specifically, cloud-based MES integrates real-time information of different production floors and promotes collaboration.  Driven by the ongoing innovation in the industry, as well as the rise in demand for automated solutions, the manufacturing execution system providers market for the healthcare sector is likely to witness positive growth over the coming years.

The market is characterized by the presence of very large companies (more than 10,000 employees), large players (501-10,000 employees), mid-sized companies (51-500 employees) and small companies (less than 50 employees). It is worth mentioning that mid-sized companies are pre-dominantly contributing to this field. Notably, the industry has also witnessed contributions from several very large firms such as (in alphabetical order) Dassault Systèmes, Emerson, Honeywell and Samsung SDS.

It was observed that majority of the deals (both local and international) were inked by players based in the Europe. Further, in most (~24%) of the intercontinental agreements, the service provider was observed to be based in Europe, while its collaborator was headquartered in North America.

Value creation framework includes an insightful depiction for implementation of several advanced tools and technologies at different production steps, such as performance analysis, data storage, document control and process tracking which can assist providers to address unmet needs associated in this domain. Additionally, it provides a detailed analysis on ease of implementation, associated risk and value creation in integrating such tools / technologies, based on the trends highlighted in published literature and patents.

However, it is important to consider that the constant management of such enormous volumes of data is a quite tedious process and challenging process. Specifically, management and handling of huge datasets in the healthcare industry often requires a large workforce of specialized personnel. According to the American Hospital Association, by 2026, there is likely to be a shortage of 3.2 million healthcare workers.  The continuously growing data, coupled to the projected deficit of healthcare workers, would inadvertently generate pressure on healthcare manufacturers to adopt novel tools / technologies that can improve management efficiency and better utilize the available, expensive resources.

Moreover, increasing complexity of healthcare manufacturing operations, along with growing stringency and frequent changes in regulatory requirements has created a dire need for adoption of automated solutions, such as manufacturing execution system (MES).

Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs.

To view more details on this report, click on the link

https://www.rootsanalysis.com/reports/manufacturing-execution-systems-market.html

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

We specialise in analysing areas which have lacked quality research so far or require more focused understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

The research efforts are driven by a global team. The leadership team brings a wealth of experience within the sector. Their collective experience in pharmaceutical / affiliated domains allows us to tackle various areas of research in a structured way. We also regularly leverage our global network of experts who hold senior leadership positions in reputed firms and organisations worldwide.

Contact:

Roots Analysis

+1 (415) 800 3415

[email protected]